WILEX AG: Redectane meets both endpoints specificity and sensitivity with ... - PharmaLive.com (press release) PDF Print
PharmaLive.com (press release)In contrast to the preliminary data published in November 2009, the endpoint sensitivity, the correct diagnosis that clear cell renal cell cancer is present

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.